Portfolio Update

Finsbury Emerging Biotechnology Tst
03 October 2006



                                                                  3 October 2006





                  FINSBURY EMERGING BIOTECHNOLOGY TRUST PLC
                                (the "Company")



                       QUARTERLY STATEMENT OF INVESTMENTS


In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii),
the Company discloses the following:


  • Investments valuing greater than 5% of the Company's gross assets comprise
    the following:


Company Name                                                       Value of Investment at       % of Total
                                                                      30 September 2006      Portfolio  Assets

AMGEN COM USD0.0001                                                       6,944,465                9.55
GENENTECH INC COM STK USD0.02 NPV                                         5,134,442                7.06
GENZYME CORP GENERAL DIVISION COM USD0.01                                 4,911,566                6.75





  • The ten largest investments held by the Company comprise the following:


Company Name                                                       Value of Investment at       % of Total
                                                                 30 September 2006           Portfolio Assets

AMGEN COM USD0.0001                                                       6,944,465                9.55
GENENTECH INC COM STK USD0.02 NPV                                         5,134,442                7.06
GENZYME CORP GENERAL DIVISION COM USD0.01                                 4,911,566                6.75
MEDIMMUNE INC COM USD0.01                                                 3,525,656                4.85
GILEAD SCIENCES INC COM USD0.001                                          3,129,340                4.30
VERTEX PHARMACEUTICALS COM USD0.01                                        2,878,021                3.96
ONYX PHARMACEUTICALS COM USD0.001                                         2,605,701                3.58
GENMAB A/S DKK1 (BEARER)                                                  2,562,179                3.52
INTERMUNE INC COM STK USD.001                                             2,342,745                3.22
GEN-PROBE INC USD0.0001                                                   2,280,420                3.13







                                    - ENDS -



For further information please contact:
Tracey Lago, Senior Company Secretary
Close Finsbury Asset Management Limited
Telephone: [phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange